Abstract
Background
Although weight loss has been implicated in anti-diabetic effects, sleeve gastrectomy (SG)-mediated anti-diabetic effects are induced through mechanisms beyond weight loss. Our aim was to investigate whether anti-diabetic effects can be achieved by surgically removing a smaller portion of the stomach instead of SG.
Methods
Male 11-week-old Goto–Kakizaki rats (N = 50) were randomized into five groups: sub-sleeve gastrectomy (SSG, only the gastric fundus is removed), SG, sham-operated SSG, sham-operated SG, and control. Body weight, food intake, hormone secretion, and glucose metabolism were measured up to 24 weeks after surgery.
Results
The data showed that (i) both SSG and SG surgeries significantly improved glucose homeostasis, with lower ghrelin levels and higher post-prandial glucagon-like peptide 1, peptide YY, and insulin levels; (ii) SG, but not SSG, produced sustained weight loss and significant reduction of food intake; and (iii) SG induced better long-term diabetic improvement than SSG.
Conclusions
The SSG that only removed the gastric fundus exhibited significant diabetic improvement without weight loss, but did not induce long-term diabetic improvement comparable to that of SG. Our study helps to understand the role of hormones and weight loss in maintaining long-term diabetes improvement after SG.
Similar content being viewed by others
References
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324
Vidal J, Ibarzabal A, Romero F, Delgado S, Momblan D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18:1077–1082
Chambers AP, Stefater MA, Wilson-Perez HE, Jessen L, Sisley S, Ryan KK, Gaitonde S, Sorrell JE, Toure M, Berger J, D’Alessio DA, Sandoval DA, Seeley RJ, Woods SC (2011) Similar effects of Roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav 105:120–123
Karra E, Yousseif A, Batterham RL (2010) Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 21:337–344
Ahn SM, Pomp A, Rubino F (2010) Metabolic surgery for type 2 diabetes. Ann N Y Acad Sci 1212:E37–E45
Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE (2010) Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 6:102–109
Pereferrer FS, Gonzalez MH, Rovira AF, Blasco SB, Rivas AM, del Castillo Dejardin D (2008) Influence of sleeve gastrectomy on several experimental models of obesity: metabolic and hormonal implications. Obes Surg 18:97–108
Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK (2008) Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:401–407
Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, Gfrerer L, Ludvik B, Zacherl J, Prager G (2010) Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 20:535–540
Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, Coccia F, Borgonuovo G, De Luca ML, Asprino R, Alessandri G, Casella G, Leonetti F (2011) First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 25:3540–3550
Pech N, Meyer F, Lippert H, Manger T, Stroh C (2012) Complications and nutrient deficiencies two years after sleeve gastrectomy. BMC Surg 12:13
Li F, Zhang G, Liang J, Ding X, Cheng Z, Hu S (2009) Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto–Kakizaki rats. J Gastrointest Surg 13:2302–2308
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Boza C, Salinas J, Salgado N, Perez G, Raddatz A, Funke R, Pimentel F, Ibanez L (2012) Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg 22:866–871
Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m2. Surg Today 38:399–403
Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, Basso N (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24:1005–1010
Shah PS, Todkar JS, Shah SS (2010) Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 6:138–141
Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM (2010) Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 147:664–669
Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW (2010) Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 252:966–971
Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261
Couce ME, Cottam D, Esplen J, Schauer P, Burguera B (2006) Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 16:870–878
Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88:2999–3002
Carrasco F, Rojas P, Csendes A, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, Watkins G, Rojas J, Ruz M (2012) Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes. Nutrition 28:757–761
Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004) Ghrelin: a hormone with multiple functions. Front Neuroendocrinol 25:27–68
Tymitz K, Engel A, McDonough S, Hendy MP, Kerlakian G (2011) Changes in ghrelin levels following bariatric surgery: review of the literature. Obes Surg 21:125–130
Dezaki K, Sone H, Yada T (2008) Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118:239–249
Romero F, Nicolau J, Flores L, Casamitjana R, Ibarzabal A, Lacy A, Vidal J (2012) Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:2231–2239
Gaitonde S, Kohli R, Seeley R (2012) The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition. J Surg Res 178:33–39
Mingrone G (2008) Role of the incretin system in the remission of type 2 diabetes following bariatric surgery. Nutr Metab Cardiovasc Dis 18:574–579
Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, Donini A (2005) Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg 15:1258–1264
Wang TT, Hu SY, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247:968–975
Masuda T, Ohta M, Hirashita T, Kawano Y, Eguchi H, Yada K, Iwashita Y, Kitano S (2011) A comparative study of gastric banding and sleeve gastrectomy in an obese diabetic rat model. Obes Surg 21:1774–1780
Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C (2012) Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 22:740–748
Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650–654
Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N (2010) Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg 20:50–55
van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP, Pijl H (2007) Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am J Physiol Endocrinol Metab 292:E238–E245
Konturek SJ, Pepera J, Zabielski K, Konturek PC, Pawlik T, Szlachcic A, Hahn EG (2003) Brain-gut axis in pancreatic secretion and appetite control. J Physiol Pharmacol 54:293–317
Aguirre V, Stylopoulos N, Grinbaum R, Kaplan LM (2008) An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring) 12:2585–2592
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 81270888/H0713, No. 81070642/H0713, No. 81370496/H0308, No. 81300286/H0308), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20100131110049), Shandong Provincial Outstanding Medical Academic Professional Program, Natural Science Foundation of Shandong Province Grants (No. ZR2012HQ030), and Graduate Independent Innovation Foundation of Shandong University (No. yzc11068).
Disclosures
Dong Sun, Shaozhuang Liu, Guangyong Zhang, Punsiri Colonne, Chunxiao Hu, Haifeng Han, Mingxia Li and Sanyuan Hu declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dong Sun, Shaozhuang Liu, and Guangyong Zhang have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sun, D., Liu, S., Zhang, G. et al. Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model. Surg Endosc 28, 1010–1018 (2014). https://doi.org/10.1007/s00464-013-3272-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-013-3272-1